MarketPeel
Insider Trading Intelligence
MA

Matthew Angel

BTX
INTERIM PRESIDENT AND CEO · BLACKROCK TECHNOLOGY & PRIVATE EQUITY TERM TRUST · CIK 0001931356
FILING MIX · LIFETIME100%/0%
BUYS
7
SELLS
0
TOTAL VALUE
$1.00M
COMPANIES
3
ACTIVE SINCE
Aug 2022
HOLDINGS NOW
2,850,488
AVG SELL PX
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Matthew Angel, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-6.29%-0.43%-5.85%-5.85%
14d1+0.00%-10.86%+0.93%-11.78%-11.78%
30d1+100.00%+2.86%+8.46%-5.61%-5.61%
60d1+100.00%+8.00%
90d1+0.00%-29.71%+14.32%-44.04%-44.04%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY SELL
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 7 buys / 0 sellsCOVERAGE · 15 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASE
CEO and President
231,482$2.16$500.0K231,482Mar 24, 2026Mar 25, 2026View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASE
CEO and President
231,482231,482Mar 24, 2026Jun 23, 2026View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASE
CEO and President
231,482$2.16$500.0K231,482Mar 24, 2026Jun 23, 2026View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASE
CEO and President
231,482231,482Mar 24, 2026Jun 23, 2026View →
TPST
TEMPEST THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
269,621269,621Feb 4, 2026Feb 6, 2026View →
ERNA
ERNEXA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
132,003132,003Jan 12, 2023Jan 13, 2023View →
BTX
BLACKROCK TECHNOLOGY & PRIVATE EQUITY TERM TRUST
PURCHASEGRANT
Stock grant
2,487,0032,487,003Aug 1, 2022Aug 3, 2022View →
Other insiders · BTX
Loading peer insiders…
About this filer
CIK 0001931356
ROLE
Interim President and CEO
PRIMARY
BTX
COMPANIES
3
ACTIVE SINCE
Aug 2022
MARKETPEEL · /INSIDER/0001931356DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback